5 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 5 separate news trends connected to Johnson & Johnson, spanning June 27, 2026 through September 12, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 33 article observations and 32 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Apollo Global in talks to acquire Johnson & Johnson's orthopedics unit for $20 billion.
Cullinan and Taiho's lung cancer drug has passed a major clinical trial, setting up a potential challenge to Johnson & Johnson's market-leading treatment.
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Johnson & Johnson has exceeded quarterly earnings estimates and raised its financial guidance, driven by a strong performance in its medicines unit.
Lilly, Johnson & Johnson and AbbVie stocks reach unprecedented levels as investors shift from tech to healthcare.